Opko Health OPK Pharmaceutical — Total Assets

Other segment segments

Similar metrics at other companies

GYREGyre Pharmaceuticals — Total Assets

$139.24M+14.9%

ABTEstablished Pharmaceuticals — Total Assets

$3.82B+2.3%

CAHPharmaceutical and Specialty Solutions — Total Assets

$41.03B+14.8%

EQHAsset Management — Total Assets

$10.34B-3.4%

KKRAsset Management — Total Assets

$28.02B-0.3%

APOAsset Management — Total Assets

$21.76B+44.5%

FAQ

What is Opko Health's pharmaceutical — total assets?

Opko Health (OPK) reported pharmaceutical — total assets of $1.28B in Q2 2026.

How has Opko Health's pharmaceutical — total assets changed year-over-year?

Opko Health's pharmaceutical — total assets decreased by 5.0% year-over-year, from $1.34B to $1.28B.

What is the long-term trend for Opko Health's pharmaceutical — total assets?

Over 3 years (2021 to 2024), Opko Health's pharmaceutical — total assets has grown at a 4.5% compound annual growth rate (CAGR), from $4.53B to $5.17B.

What does pharmaceutical — total assets mean?

This metric represents the total value of resources owned or controlled by the pharmaceutical segment, including property, plant, equipment, inventory, and intangible assets. It serves as a measure of the scale and capital base dedicated to pharmaceutical research, development, and commercialization. Analyzing this figure allows for the assessment of asset utilization and the segment's overall contribution to the company's balance sheet.